Simvastatin Tablet, Film Coated
Product Images NDC 68084-511
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Simvastatin (NDC 68084-511). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
10 mg Carton
This is a medication called Simvastatin, which comes in a bottle of 100 tablets and requires a prescription to purchase. Each tablet contains an unspecified amount of the active ingredient called Sinvastatin USP. The usual adult dosage information can be found in the package insert. It is recommended to store the medication at room temperature. This medication should be kept out of reach of children and shouldn't be used if the packaging is damaged. The medication is distributed by American Health Packaging based in Columbus, Ohio. The given alphanumeric text is mostly unreadable, so it is ignored.*
20 mg Blister
20 mg Carton
This is a description of a medication called Simvastatin. The NDC number of this medication is 68084-512-01, and it is a USP tablet that is used for adult dosage only. The medication comes in a pack of 100 tablets (10 x 10), and each film-coated tablet contains Simvastatin USP 20mg. The medication should be stored within a temperature range of 20-25°C (68-77°F) and protected from children. The manufacturer of this medication is Lupin Pharmacoutcal, Inc., and it is distributed by American Health Packaging in Columbus, OH.*
Ahp51101
Ahp51201
Figure 1
The text is a chart with data reflecting the effects of treatment with Simvastatin on Major Vascular Events and Major Coronary Events in HPS. It shows the incidence of major events for patients with and without CHD, diabetes mellitus, peripheral vascular disease and cerebrovascular disease, grouped by age, gender and cholesterol levels. The chart also shows the risk ratio for each of these categories.*
Structure
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.